Grant: Project Grant - PA: Nutrition, Metabolism and Diabetes
Sunnybrook Research Institute (Toronto, Ontario)
$100,000.00
Role of the GPR3-SIK2 Pathway in Human Beta Cell Proliferation
EF 2021-22
Résumé
Our vision is to establish a complete understanding of the biology of human beta cells, the
cells that make and secrete insulin after a meal. The inability to produce enough insulin
results in diabetes mellitus (DM), and affects over 13M Canadians. While it is widely held that
treating DM will require improving the health of the human beta cell, our current knowledge of
the basic properties of the human beta cell are lacking. We will use cutting-edge genetic
technology to provide a complete understanding of how both mature adult human beta cells
and their stem cell precursors grow, divide and secrete insulin. Furthermore, we will explore
targeting a novel pathway we discovered that when activated helps to increase beta cell
function in response to high sugar levels and promotes beta cell proliferation for prevention
and treatment of DM.
Programme
Project Grant - PA: Nutrition, Metabolism and Diabetes
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
456702
Name
Screaton Robert A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Diabetes, Obesity, Lipid & Lipoprotein Disorders
Projecttitle
Role of the GPR3-SIK2 Pathway in Human Beta Cell Proliferation
Programtype2
Operating Grants
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Nutrition, Metabolism and Diabetes
Keyworddelim
Cell Cycle; Diabetes; Functional Genomics; Gpcrs; Islets; Metabolism; Proliferation; Regeneration; Rnai
Abstract
Our vision is to establish a complete understanding of the biology of human beta cells, the
cells that make and secrete insulin after a meal. The inability to produce enough insulin
results in diabetes mellitus (DM), and affects over 13M Canadians. While it is widely held that
treating DM will require improving the health of the human beta cell, our current knowledge of
the basic properties of the human beta cell are lacking. We will use cutting-edge genetic
technology to provide a complete understanding of how both mature adult human beta cells
and their stem cell precursors grow, divide and secrete insulin. Furthermore, we will explore
targeting a novel pathway we discovered that when activated helps to increase beta cell
function in response to high sugar levels and promotes beta cell proliferation for prevention
and treatment of DM.
Competitiondate
202109
Approvedterm2
1 yr 0 mth
Pinamesdelim
Screaton, Robert A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~